Response to Letter to the Editor: Toward Precision Medicine in Portal Hypertension: Insights From the Carvedilol Versus Propranolol Meta‐Analysis

Key Points

• Portal hypertension treatment strategies show distinct effectiveness between carvedilol and propranolol, influencing clinical choices.
• The findings highlight a significant difference in hepatic venous pressure gradient reduction between the two medications.
• Meta-analysis utilized previously published data on liver cirrhosis, comparing both drugs' impacts on measures of portal hypertension.
• Implications of this analysis support precision medicine approaches, crucial for optimizing treatment outcomes in patients.

Abstract